Cargando…

DPP4 inhibition prevents AKI

Detalles Bibliográficos
Autores principales:	Reichetzeder, Christoph, Hocher, Berthold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630283/ https://www.ncbi.nlm.nih.gov/pubmed/29029383 http://dx.doi.org/10.18632/oncotarget.20212

Ejemplares similares

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
por: von Websky, Karoline, et al.
Publicado: (2013)

Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy
por: Chaykovska, Lyubov, et al.
Publicado: (2011)

Paternal Body Mass Index (BMI) Is Associated with Offspring Intrauterine Growth in a Gender Dependent Manner
por: Chen, You-Peng, et al.
Publicado: (2012)

Clinical Advances in Kidney Failure: AKI
por: Awad, Alaa S., et al.
Publicado: (2023)

DPP‐4 inhibition and islet function
por: Ahrén, Bo
Publicado: (2011)

DPP-4 inhibitors and severe course of illness in patients with COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2021)

Sepsis and AKI: A Two-Way Street
por: Basalely, Abby, et al.
Publicado: (2023)

DPP-4 Inhibition and the Path to Clinical Proof
por: Ahrén, Bo
Publicado: (2019)

Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI
por: Ostermann, Marlies, et al.
Publicado: (2021)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress – Do We Need a Fourth Generation Parathyroid Hormone Assay?
por: Hocher, Berthold, et al.
Publicado: (2012)

Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma
por: Horie, Kuniko, et al.
Publicado: (2023)

Section 3: Prevention and Treatment of AKI
Publicado: (2012)

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
por: Solerte, Sebastiano Bruno, et al.
Publicado: (2020)

DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?
por: Shannon, Richard P.
Publicado: (2013)

Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor
por: Wang, Aiying, et al.
Publicado: (2012)

Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy—effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker
por: Xiong, Yingquan, et al.
Publicado: (2022)

DPP4 in Diabetes
por: Röhrborn, Diana, et al.
Publicado: (2015)

Association of BMAL1 clock gene polymorphisms with fasting glucose in children
por: Yang, Yi-De, et al.
Publicado: (2023)

Is urine microscopy a useful early biomarker for cardiac surgeryrelated AKI?
por: Perazella, Mark A.
Publicado: (2020)

Pregnancy-Related AKI: A Tertiary Care Hospital Experience in Somaliland
por: Rage, Hamze Ibrahim, et al.
Publicado: (2023)

Head‐to‐head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury
por: Reichetzeder, Christoph, et al.
Publicado: (2017)

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
por: Shirakawa, Jun, et al.
Publicado: (2011)

Section 4: Contrast-induced AKI
Publicado: (2012)

Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial
por: Meersch, Melanie, et al.
Publicado: (2017)

Paternal eNOS deficiency in mice affects glucose homeostasis and liver glycogen in male offspring without inheritance of eNOS deficiency itself
por: Hocher, Berthold, et al.
Publicado: (2022)

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI
por: Li, Hai-Lun, et al.
Publicado: (2018)

Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis
por: Schulz, Kirsten, et al.
Publicado: (2015)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
por: Liu, Jinglong, et al.
Publicado: (2014)

Risk factors associated with preterm birth after IVF/ICSI
por: Li, Jian, et al.
Publicado: (2022)

Is DPP4 inhibition a comrade or adversary in COVID-19 infection
por: Dalan, Rinkoo
Publicado: (2020)

Tackling AKI: prevention, timing of dialysis and follow-up
por: Vijayan, Anitha
Publicado: (2020)

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
por: Zhang, Tianli, et al.
Publicado: (2021)

Increased global placental DNA methylation levels are associated with gestational diabetes
por: Reichetzeder, C., et al.
Publicado: (2016)

Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans
por: Baggio, Laurie L., et al.
Publicado: (2020)

Epidemiology of AKI: Utilizing Large Databases to Determine the Burden of AKI
por: Sawhney, Simon, et al.
Publicado: (2017)

Latent AKI is… still AKI: the quantification of the burden of renal dysfunction
por: Ricci, Zaccaria, et al.
Publicado: (2016)

Role of pediatric nephrologists in managing adults with AKI due to COVID-19
por: Lipton, Marissa, et al.
Publicado: (2020)

Clinical Use of DPP-4 Inhibitors
por: Gallwitz, Baptist
Publicado: (2019)

Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mtl2muqdsrb9nd1i09n940c98u